Therapeutically enhanced saliva-activatable cellulosic product
OwnerTodd A. Blandinventor
Life of this patent
Estimating the term…
Abstract
Therapeutically Enhanced Saliva-Activatable Cellulosic Product comprising a conventional flexible cellulosic paper item having parallel horizontal broad surfaces including an upper-surface and a lower-surface and which surfaces are intersected by an upright longitudinal-edge, said conventional cellulosic paper item being non-conventionally augmented at the upper-surface thereof and nearby along a longitudinal-edge with a saliva-activatable therapeutic-layer carrying at the topical-surface thereof a selectable therapeutic-agent. Among such generally available conventional cellulosic paper items, and thus available for saliva-activatable therapeutic enhance, are conventional rollably secureable cigarette papers, mailing envelopes, epidermally-adherent body bandages, etc.
Claims10
Therapeutically Enhanced Saliva-Activatable Cellulosic Product comprising a flexibly rollable conventional cellulosic, cigarette paper item having parallel horizontal broad surfaces including an upper-surface and a lower-surface both extending directionally longitudinally along a central-axis that is flanked by two longitudinally extending upright lengthwise-edges, said conventional cellulosic cigarette paper item having along a first longitudinal-edge at said upper-surface a saliva-moistable first-strip adhesive-layer, a longitudinally extending second-strip adhesive-layer located at said upper-surface between said first-strip and said central-axis, said second-strip carrying at a directionally longitudinal topical-surface thereof, a saliva activaiable therapudic agent selected from a group consisting of aspirin and polyvinyl acetate phthalate.
Therapeutically Enhanced Saliva-Activatable Cellulosic Product environmentally comprising a conventional cellulosic mailing envelope having a foldable flap portion directionally longitudinally provided with a first-strip adhesive-layer and with a saliva-activatable therapeutic agent located at the topical surface of said first-strip adhesive-layer.
Dependencies are inferred from the claim text.